Eagle Pharmaceuticals Inc (NASDAQ:EGRX)

43.28
Delayed Data
As of 3:59pm ET
 +1.15 / +2.73%
Today’s Change
36.48
Today|||52-Week Range
56.16
-7.06%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$551.8M

Company Description

Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.

Contact Information

Eagle Pharmaceuticals, Inc.
50 Tice Boulevard
Woodcliff Lake New Jersey 07677-9991
P:(201) 326-5300
Investor Relations:

Employees

Shareholders

Mutual fund holders53.85%
Individual stakeholders47.54%
Other institutional42.36%

Top Executives

Scott L. TarriffChief Executive Officer & Director
David M. PernockPresident & Chief Operating Officer
Brian CahillChief Financial Officer
Judith Ng-CashinChief Medical Officer & Executive Vice President
Daniel O'ConnorChief Strategy Officer